These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 34359959)

  • 1. Cerebral Organoids-Challenges to Establish a Brain Prototype.
    Eremeev AV; Lebedeva OS; Bogomiakova ME; Lagarkova MA; Bogomazova AN
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
    Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
    Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
    Silva-Pedrosa R; Salgado AJ; Ferreira PE
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
    Pazzin DB; Previato TTR; Budelon Gonçalves JI; Zanirati G; Xavier FAC; da Costa JC; Marinowic DR
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Characterization of Structural, Molecular, and Electrophysiological Phenotypes of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids, and Comparison with Fetal and Adult Gene Profiles.
    Logan S; Arzua T; Yan Y; Jiang C; Liu X; Yu LK; Liu QS; Bai X
    Cells; 2020 May; 9(5):. PubMed ID: 32456176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoids: Avatars for Personalized Medicine.
    Clevers HC
    Keio J Med; 2019; 68(4):95. PubMed ID: 31875622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Transcriptomic Analysis of Cerebral Organoids and Cortical Neuron Cultures Derived from Human Induced Pluripotent Stem Cells.
    Kathuria A; Lopez-Lengowski K; Watmuff B; Karmacharya R
    Stem Cells Dev; 2020 Nov; 29(21):1370-1381. PubMed ID: 32862797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models.
    Kiaee K; Jodat YA; Bassous NJ; Matharu N; Shin SR
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids.
    Pecksen E; Tkachuk S; Schröder C; Vives Enrich M; Neog A; Johnson CP; Lachmann N; Haller H; Kiyan Y
    Stem Cell Res Ther; 2024 May; 15(1):132. PubMed ID: 38702808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconstructing and reconstructing the human brain with regionally specified brain organoids.
    Xiang Y; Cakir B; Park IH
    Semin Cell Dev Biol; 2021 Mar; 111():40-51. PubMed ID: 32553582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery.
    Costamagna G; Andreoli L; Corti S; Faravelli I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.
    Csobonyeiova M; Polak S; Danisovic L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids.
    Qu Y; Han B; Gao B; Bose S; Gong Y; Wawrowsky K; Giuliano AE; Sareen D; Cui X
    Stem Cell Reports; 2017 Feb; 8(2):205-215. PubMed ID: 28132888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism.
    Jung-Klawitter S; Opladen T
    J Inherit Metab Dis; 2018 Nov; 41(6):1103-1116. PubMed ID: 29980968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling mitochondrial diversity in brain function: from animal models to human brain organoids.
    Menacho C; Prigione A
    Int J Biochem Cell Biol; 2020 Jun; 123():105760. PubMed ID: 32339638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.